SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities who purchased of Inspire Medical Systems, Inc. (NYSE:INSP) common stock between May 3, 2023 and November 7, 2023. Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea ("OSA").
For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is this Case About: Inspire Medical Systems, Inc. (INSP) Misled Investors Regarding Issues with its Acceleration Program
According to the complaint, during the class period, defendants failed to disclose that: (1) despite the Acceleration Program, customers were encountering challenges with the prior authorization submission process, including with the scheduling of appointments; and (2) a slowdown in prior authorization submissions ...